NovaBay Pharmaceuticals Inc. (NBY) Gained 8.89% or 0.2 To Price $2.45 On Tuesday


NovaBay Pharmaceuticals Inc. (NBY) gained 8.89% or 0.2 to $2.45. It is nearly 62500 shares traded, which is 1498.8% compare to the average total volume 4170. The market cap of NBY is $41.87 million. The year to date change is -36.23%. The 52 week price range is from $2.0 to $5.0. Price of NBY have changed -2.17% during last week. It have changed -10.00% over last month, -29.58% over last 3 months, -39.19% over last 6 months and -46.43% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBY is 2.48. It is 1.22% above current price. The 200-day Moving Averages for NBY is 3.37. It is 37.55% above current price. The 52-week High is 5.0. It is 104.08% from the current price. The 52-week Low is 2.0. It is -18.37% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NBY is 26.86 on 2018-07-13. Short % to float is 0.82%. There are some statistics of NBY. It is has market cap $41.87 million. The share outstanding is 17.09 million. The average volume is 4170. The revenue is 8.21M. The gross profit is 6.99M. The percent of top 15 Institution holding is 10.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBY is -83.80%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBY is -41.82%.


Tags:

Share this post